We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

apceth Receives Approval for a Clinical Cancer Trial with Adult Mesenchymal Stem Cells

News   Jun 14, 2013

 
apceth Receives Approval for a Clinical Cancer Trial with Adult Mesenchymal Stem Cells
 
 
Advertisement
 

RELATED ARTICLES

Head and Neck Cancer: Mutant HRAS Is a Key Cancer-Driving Oncogene

News

Researchers report that an investigational drug called tipifarnib shows promise in treating head and neck squamous cell carcinoma tumors with mutations in the HRAS gene.

READ MORE

Potential New Treatment Tactic for Acute Myeloid Leukemia

News

Researchers demonstrate that factors produced by bone marrow support cells allow leukemia cells to survive treatment with quizartinib. When quizartinib was combined with another tyrosine kinase inhibitor called dasatinib the alternative survival pathways were shut down, leading to more effective leukemia cell death.

READ MORE

Neural Progenitor Cells Discovered in the Optic Nerve

News

Researchers at the University of Maryland School of Medicine have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding presents a new theory on why the most common form of glaucoma may develop and provides potential new ways to treat a leading cause of blindness in American adults.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE